Characteristics of Patients Initiated on Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Single Inhaler Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Population-Based Observational Study

Characteristics of Patients Initiated on Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Single Inhaler Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Population-Based Observational Study

Gaétan Deslee,1 Caroline Fabry-Vendrand,2 Elsa Salmi,2 Nolwenn Poccardi,2 Adrien Coriat,3 Idir Ghout,3 Caroline Eteve-Pitsaer,3 Nicola J Adderley,4 Henri Leleu5 1Service de Pneumologie, INSERM UMRS-1250, Centre Hospitalier Universitaire de Reims, Université Reims, Champagne-Ardenne, France; 2AstraZe...

Full description

Saved in:
Bibliographic Details
Main Authors: Deslee G, Fabry-Vendrand C, Salmi E, Poccardi N, Coriat A, Ghout I, Eteve-Pitsaer C, Adderley NJ, Leleu H
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:International Journal of COPD
Subjects:
chronic obstructive pulmonary disease
triple therapy
budesonide/glycopyrronium bromide/formoterol fumarate
management
Online Access:https://www.dovepress.com/characteristics-of-patients-initiated-on-budesonideglycopyrronium-brom-peer-reviewed-fulltext-article-COPD
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items